Sunmax Biotechnology Co., Ltd.  

Founded in 2001, SunMax Biotechnology Co., Ltd., which is headquartered in Tainan Science-based Industrial Park, south Taiwan, specializes in the production of high-quality, cost-effective porcine collagen used in biochemistry research, medical applications and cosmetics. SunMax Biotechnology focuses its collagen-
related R&D efforts on biomedical materials, such as wound dressings, atelocollagen implants, and hemostats. Equipped with cGMP’s facilities and complying with rigorous quality-control standards, SunMax Biotechnology is committed to producing an array of high-quality biomedical products.

EOS Pharmaceutical Corp., located in a technology-rich suburb of Boston, Mass., U.S.A., has extensive experience in developing dermatological and skin-care products. In past decades, EOS research teams have devoted substantial time and energy on the development of drug- delivery systems, including bioadhesive delivery systems, transdermal delivery systems, topical delivery systems and cosmeceuticals. In combination with its unique formulation and manufacturing quality, EOS has produced a wide range of effective pharmaceutical and cosmetic products. The excellence of the products has earned the acclaim of the scientific community.

Together, SunMax and EOS have recently introduced Essencoll Collagen Skin Care series Products to the international markets.
Essencoll, Collagen, cosmetic, implant, sunmax, skin, biotechnology, refining Cream, Collagen Moisturizing Cream, Collagen Reviving Serum, Collagen Facial Cleanser, Biomedical Grade Collagen Solution, Collagen Pad, Collagen Hemostat, Collagen Implant